Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: ANI Pharmaceuticals
LEI 5493000T6CXTND40YH31

Nom de l'organisation
ANI Pharmaceuticals, Inc.
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
-

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company manufactures oral solid dose products, as well as liquids and topicals, narcotics, and potent products; and Lithobid lithium carbonate extended release tablets. Its targeted areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products.

Récompenses

Actualités

17/04/2024 ANI Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Exhibits
12/03/2024 ANI Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Exhibits
29/02/2024 ANI Pharmaceuticals: Results Of Operations And Financial Condition, Exhibits
21/02/2024 Moody's Investors Service revised outlook on ANI Pharmaceuticals to positive and affirmed at "B2" (LT- foreign currency) credit rating
21/02/2024 Moody's revises ANI Pharmaceuticals' outlook to positive; affirms B2 CFR (Rating action commentary)
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    5493000T6CXTND40YH31
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001023024
  • EIN
    58-2301143

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.